
NEW Kidney Cancer UK Patient Survey 2023 Report FINDS KIDNEY CANCER PATIENTS ARE BEING MISDIAGNOSED, CONFUSED ...

Kidney Cancer UK is delighted to present our first Webinar for 2024 on Tuesday January 16th at 6pm, ‘Counselling – ...

Merck partners with HiberCell for Phase Ib renal carcinoma trial
The Phase Ib trial will evaluate the ...

Living with a rare disease can be challenging enough, especially when it impacts you physically. But for those ...

A secondary analysis from the SWOG S0931 EVEREST trial has found that in the subgroup of patients with clear-cell ...

The drug response predictor companion diagnostic for dovinitib (DRP-Dovitinib) demonstrates potential to identify ...

Exploring how to match treatments to patients
Patients with advanced or metastatic kidney cancer now have a range ...

The National Institute for Health and Care Excellence (NICE) is recruiting members for the committee that will ...

Investigators have found that inhibition of the purine salvage pathway in hereditary leiomyomatosis and renal cell ...

The National Cancer Research Institute (NCRI) has announced that it will be winding down its operations prior to ...

Kidney Cancer UK is delighted to announce that collaboration with senior NHS clinicians has resulted in the ...

A cancer patient from West Yorkshire has become the first person in the world to have a kidney tumour removed ...